GRIFOLS SHARED SERVICES NORTH AMERICA INC

H.R. 6465, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 5818, Medicare IVIG Access Enhancement Act of 2023. H.R. 4438, John W. Walsh Alpha-1 Home Infusion Act of 2023.

Issues related to the implementation of P.L. 117-169, The Inflation Reduction Act.

Educational meetings on Grifols, presence in district/state, and unique cost considerations of plasma medicines; House and Senate meetings to advance HR 6465 to provide a phase-in for plasma therapies of the Medicare Part D catastrophic coverage rebate of 20% mandated under the Inflation Reduction Act. Meetings to advocate for home infusion coverage of plasma therapies for rare diseases such as Alpha-1 Antitrypsin Deficiency and Chronic Inflammatory Demyelinating Polyneuropathy. Meetings to advocate for Medicare coverage of IVIG to great primary immune deficiency in the skilled nursing facility setting.

FY2024 Appropriations Request Supporting blood and plasma donation awareness

Issues around implementation of 2022 H.R. 5376 - "Inflation Reduction Act of 2022"